Biosimilars
Multiple growth levers for Biocon; ramp-up, new biosimilars to boost profit
US to lead Biocon Biologics' drive towards $1 billion revenue
Biosimilar market on the growth path as top drugs double in size
Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO
Indian biosimilar market likely to touch $1 billion in three years

Indian biosimilars market may reach $40 billion by 2030: Assocham report